NUT midline carcinomas (NMCs) comprise a group of highly aggressive tumors that have been reported primarily in the head, neck, and mediastinum of younger individuals. These tumors overexpress the nuclear protein in the testis (NUT), most commonly due to a chromosomal translocation that fuses the NUT gene on chromosome 15 with the BRD4 gene on chromosome 19. Although the earliest recognized cases were described in the thymus or mediastinum, an extensive survey for NMCs among malignant thymic or other mediastinal neoplasms has not been reported. We examined NUT expression in 114 cases of poorly differentiated carcinomas or unclassified mediastinal malignancies using a clinically validated NUT-specific monoclonal antibody. Four of 114 (3.5%) cases showed nuclear NUT expression. A NUT translocation was confirmed by fluorescence in situ hybridization in 3 of these cases. These tumors arose in 2 men and 2 women with a median age of 50 years (range, 28 to 68 y). Three of the tumors were originally diagnosed as undifferentiated epithelioid or round cell malignant neoplasms; 1 tumor contained focal squamous differentiation and was originally diagnosed as a poorly differentiated squamous carcinoma of probable thymic origin. We find that the incidence of NMC within the mediastinum, particularly among undifferentiated tumors, is similar to that reported at other anatomic sites. NMC should be considered in the differential diagnosis of any poorly differentiated epithelioid mediastinal tumor, regardless of age.
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Key Words: NUT midline carcinoma, mediastinum, squamous cell carcinoma (Am J Surg Pathol 2012;36:1222-1227) BACKGROUND Midline carcinomas with t(15;19) translocations were first described in the early 1990s in relatively young patients with mediastinal or intrathoracic carcinomas. 11, 12, 14 Since that time, the majority of reported NUT-translocated carcinomas have been described in midline head, neck, and thoracic structures, although additional locations such as the abdomen and iliac bone have also been reported. 5, 6 To date, the histopathology of at least 39 individual cases has been reported in the literature. In most cases, NUT midline carcinomas (NMCs) appear morphologically and immunohistochemically undifferentiated. In a subset of cases, focal and abrupt squamous differentiation can be seen adjacent to poorly differentiated areas of the tumor. 10, 18 Patients with NMC typically present with a large tumor burden, mass effect, and distant metastases at the time of diagnosis. Aside from single case reports, NMC is uniformly fatal with an average survival of 9.4 months from the time of diagnosis (unpublished data), consistent with its undifferentiated morphology and typically advanced stage at presentation. 5, 17 Initially thought to be a malignancy of the young, NMC has now been reported over a wide age range, from infancy up to the age of 78 years, with the frequency of newly diagnosed adult cases outpacing pediatric ones. 5, 17, 18 NMCs are defined by rearrangements of the NUT locus at 15q14, which result in fusion with a member of the bromodomain-containing protein (BRD) family, usually BRD4 located on chromosome 19. Discovery of the BRD4-NUT fusion oncogene led to more rapid and reliable detection of NMC by fluorescence in situ hybridization (FISH) and provided insights into the role of NUT in tumorigenesis. 8, 9, 16 Nuclear overexpression of the resulting BRD4-NUT fusion protein is detectable by immunohistochemical staining with a highly sensitive and specific NUT monoclonal antibody; as a result, diagnosis is no longer predicated upon demonstrating specific chromosomal rearrangements with FISH. 10 Despite the original reports describing t(15;19) translocated tumors arising in the mediastinum, there are no published studies describing the clinicopathologic features of NMC arising at this location, nor are there any estimates available as to its relative incidence overall or compared with the few other anatomic sites that have been studied. In this 10-year retrospective study, we perform NUT immunohistochemistry (IHC) to identify undiagnosed NMC among all thymic carcinomas and undifferentiated mediastinal malignancies available from the files of the Department of Pathology, Brigham and Women's Hospital (BWH) (both adult and pediatric patients), covering the period from 2001 to 2010 leading up to routine utilization of NUT IHC for diagnostic purposes at our institution. Newly diagnosed cases of NMC are further examined by FISH, and the clinicopathologic features of these NUT-expressing tumors are described.
METHODS

Case Selection
We queried the pathology database from BWH, including general and personal consult files from 2001 to 2010 using search terms "thymic," "mediastinal," and "carcinoma." Consults directed to C.D.M.F. for general consultation were included. Consults directed to C.A.F. for a priori suspicion of NMC, as well as tumors classified as thymomas or representing metastatic disease or contiguous spread from another site, were excluded to avoid bias. Our database search identified 180 cases of poorly differentiated thymic carcinomas or unclassified mediastinal neoplasms (including undifferentiated epithelioid, round cell, and/or spindle cell morphologies). Of these, 114 cases had sufficient material available for testing. The clinical and primary pathologic features of these 114 cases are described in Tables 1 and 2, respectively.
Clinicopathologic Review
Original diagnostic slides and associated immunohistochemical stains were reviewed by 2 pathologists (A.G.E. and L.M.S.). Patient demographic data were obtained from the medical records following approval by the BWH Institutional Review Board.
Immunohistochemistry IHC for NUT was performed on 4-mm-thick, formalin-fixed, paraffin-embedded sections as previously described. 10 Briefly, slides were subjected to heat-induced epitope retrieval in citrate buffer (pH 6) using a pressure cooker. After washing in distilled water and treatment with Peroxidase Block (Dako) for 5 minutes to quench endogenous peroxidase activity, sections were incubated with primary rabbit monoclonal anti-NUT (clone C52, 1:200) in antibody diluent (Dako) for 1 hour, washed in 50 mM Tris-HCl (pH 7.4), and incubated with horseradish peroxidase-conjugated secondary antibodies (Envision detection kit, Dako). Staining was developed through incubation with diaminobenzidine, and the sections were counterstained. Immunohistochemical staining for NUT was interpreted by 2 or more pathologists (A.G.E., L.M.S., and C.A.F.). Cases with strong, speckled nuclear staining were considered positive.
Additional immunohistochemical staining for tumor markers was performed at the time of primary diagnosis according to standard operating procedures in the Immunohistochemistry Laboratory, Department of Pathology, BWH.
Fluorescence In Situ Hybridization
Chromosomal translocation of the NUT gene locus was confirmed by FISH as previously described. 7 Dualcolor FISH assays evaluating chromosome 19p13.1 BRD4 and 15q13 NUT break points were carried out on formalin-fixed, paraffin-embedded, unstained, 4-mm-thick sections. Probes used for the 19p13.1 BRD4 break point included telomeric tandem bacterial artificial chromosome (BAC) clones RP11-319o10 and RP11-681d10 (digoxigeninlabeled, fluorescein isothiocyanate antidigoxigenin-detected, green) and centromeric BAC clones RP11-207i16 and CTD-3055m5 (biotin-labeled, rhodamine-streptavidin-detected, 
RESULTS
NUT Immunohistochemistry
Among the 114 mediastinal tumors selected (Table 2 ), a total of 4 (3.5%) showed positive NUT staining with the characteristic speckled nuclear pattern (Fig. 1) . NMC was more commonly diagnosed among consult cases (3 of 46 or 6.5%) as compared with in-house cases (1 of 68 or 1.5%).
Clinicopathologic Correlations
All cases of NMC were identified in adults, including 2 men (aged 28 and 39 y) and 2 women (aged 61 and 68 y). Additional details regarding clinical presentation were available in 3 of the 4 patients (Table 3) . Notably, no examples of NMCs were discovered among 24 tumors originally diagnosed definitively as thymic carcinoma. The NUT-positive cases demonstrated nested to sheet-like growth of monomorphic, small to intermediate-sized tumor cells with vesicular to hyperchromatic nuclei and variable amounts of cytoplasm. One case showed focal, abrupt squamous differentiation, whereas another showed abundant granular eosinophilic cytoplasm (Fig. 1 ). By IHC, 3 of 4 NMCs were negative for keratins (including a pan-keratin cocktail, Cam5.2, and/or AE1/AE3), and all were negative for sarcoma, melanoma, and lymphoma markers (for specific stains, see Table 4 ). The 1 case with extensive but focally abrupt squamous differentiation showed multifocal cytokeratin 7 (CK7) and scattered CD5-positive cells, thus leading to an original diagnosis of poorly differentiated squamous cell carcinoma of probable thymic origin (Fig. 1, Tables 3 and 4 ). This was the only case out of 84 carcinomas (B1%) that was reclassified as NMC. In comparison, the rate of NMC detection among undifferentiated neoplasms without keratin expression was higher but not by a statistically significant margin (3 of 30 or 10%; P = 0.06; Fisher exact test; Table 2 ).
FISH Correlation
FISH studies demonstrated rearrangement of the NUT locus in 3 of the 4 NUT-positive cases ( Table 4 ). Two cases showed rearrangements of both BRD4 and NUT, 1 showed rearrangement of NUT but lacked a demonstrable BRD4 rearrangement (ie, a NUT-variant translocation), and 1 case failed to show rearrangement of either BRD4 or NUT by FISH. This case likely harbored a cryptic NUT translocation (as previously described, also see the Discussion section) but lacked sufficient material to perform more comprehensive FISH analysis. 10 
DISCUSSION
This study demonstrates that NMC represents a small but appreciable percentage of poorly or undifferentiated mediastinal malignancies, including examples of both epithelioid and round cell types. Using IHC, we detected overexpression of the NUT protein in 4 of 114 (3.5%) mediastinal tumors including thymic carcinomas and difficult-to-classify malignancies. The frequency of NMC was enriched among undifferentiated mediastinal tumors (10%). To confirm the mechanism of NUT overexpression, we performed FISH for NUT and BRD4; 2 cases contained a NUT-BRD4 translocation, and 1 contained a NUT-variant translocation. One case lacked a demonstrable rearrangement using probes against NUT and BRD4 despite high levels of NUT protein expression; this case likely harbored a cryptic translocation, which is described in detail below. 10 The incidence of mediastinal NMC is within a similar range as that found at other anatomic sites. Previous reports that relied on FISH for screening demonstrated that 7% of midline carcinomas in children and young adults and 18% of undifferentiated carcinomas of the upper aerodigestive tract harbor an NUT translocation. 7, 18 In contrast, only 2 new cases of NMC were detected among a series of >1000 neoplasms that were screened by NUT IHC without being selected for histologic type or anatomic location. 10 The variable rate of detection among selected case series is most likely influenced by case-selection methodologies; in particular, the incidence reported in this and some other studies may be biased by the substantial number of cases drawn from personal consult files containing difficult-to-classify tumors. One additional previously unsuspected case of mediastinal NMC was identified in 2010 during consultation at BWH, following the introduction of routine IHC testing for NUT; this case is not included in this series. Ultimately, this study demonstrates that although NMC can be reproducibly detected by IHC among mediastinal tumors from a wide age range of patients the incidence does not indicate a strong predilection for the thymus or the mediastinum in comparison with other sites.
The large number of consult cases in this study precluded our ability to systematically examine the clinical features of this patient cohort. However, all 3 NMC cases for which some clinical details were available presented with locally and/or systemically advanced disease, consistent with prior reports of aggressive behavior.
Although it is interesting to note that NMC was identified more frequently among cases with undifferentiated histology, our study was not powered to detect a statistically significant difference in incidence between different tumor subgroups. Histologically, all 4 mediastinal NMCs in this series predominantly comprised undifferentiated round to epithelioid cells growing in nests and sheets. With the exception of rare CK7 and CD5 immunoreactivity in 1 case, all NMCs in this study were negative for a broad panel of immunohistochemical markers. These results are consistent with previous reports, which have emphasized that NMCs typically exhibit the cytologic features of a poorly differentiated or undifferentiated carcinoma. 1, 10, 19 Some cases of NMC show abrupt squamous differentiation, a feature that has been associated with NUT-variant translocations in prior reports, although this was not true of the single case with squamous dif-ferentiation in this series. 7 The frequency of squamous differentiation in this study (1 of 4) is similar to that described in a series of NMCs from the upper aerodigestive tract (2 of 5). 18 In contrast, squamous differentiation was Pathologic Characteristics of NMC in Mediastinum common (9 of 11 cases) in 1 study examining a cohort of poorly differentiated epithelial tumors from patients less than 40 years of age. 7 The presence of an NUT translocation was confirmed in 3 of the 4 NUT-overexpressing tumors identified in this study. The single FISH-negative case that exhibited strong nuclear NUT protein expression is included in the series on the basis of previous data demonstrating 100% specificity of the NUT C52 monoclonal antibody for tumors that harbor translocations involving NUT. 10 As in our series, Haack and colleagues identified 2 cases of NMC by NUT IHC that were negative using a similar FISH assay. Upon further study, these cases did in fact contain a NUT-BRD4 rearrangement, secondary to a small interstitial deletion involving the NUT gene on chromosome 15, which cannot be detected using the flanking probes used in this study (a so-called cryptic NUT rearrangement). In fact, these authors concluded that they could only attain 100% sensitivity for diagnosis of NMC by using a combined NUT IHC and a "goldstandard" FISH (ie, flanking probes) approach. 10 Because we did not use a combined screening approach in our series, our cumulative data may slightly underestimate the true incidence of mediastinal NMC seen at a tertiary care referral center.
A strength of our study is that it has examined a large number of primary mediastinal malignancies for the presence of NUT protein expression using whole-tissue slides. Although most of the NUT-positive cases were diffusely positive, there was some variable expression that may have led to false negatives had this study been performed using a tissue microarray. This study was limited by access to corresponding clinical data; therefore, it is difficult to comment on patient features associated with mediastinal NMC such as smoking status or other potential risk factors.
Studies of the molecular pathogenesis of NMC have also implicated the BRD-NUT fusion oncoprotein in squamous cell carcinogenesis. Although the role of NUT in normal tissues remains unknown, inhibition of BRD-NUT fusion proteins in NMC cell lines arrests cell growth and promotes striking and irreversible squamous cell differentiation in vitro. 5, 9 Consistent with the known role of BRD family members in chromatin remodeling, the fusion oncoproteins appear to promote epigenetic reprogramming through globally decreased histone acetylation and transcriptional repression, thus leading to undifferentiated cell growth. 16, 20 In combination, the histopathologic features described above and the laboratory data on BRD-NUT fusion protein-mediated oncogenesis support the notion that NMC is a distinctive genetic variant of squamous cell carcinoma or perhaps a relatively undifferentiated tumor arising from a common squamous cell precursor. Rapid advances in the targeted treatment of other translocation-driven tumors, such as anaplastic lymphoma kinase-rearranged lung carcinoma and BCR-ABL in chronic myelogenous leukemia, serve as exciting precedents for diagnosis and treatment of this underrecognized tumor. 3, 13 In fact, insights into the oncogenic role of BRD-NUT fusion proteins have triggered research into novel, directed therapies with histone deacetylase inhibitors and bromodomain-ET protein family members, including small-molecule inhibitors of BRD4. 2, 4, 15, 16 As with other models of targeted therapy, advancing therapeutic research beyond the preclinical stage will, by necessity, require accurate recognition of NMC. Until the clinical features of this tumor type are better clarified, the diagnosis is almost entirely dependent upon the pathologist. Our findings indicate that the diagnosis of NMC should not be overlooked in the differential of any difficult-to-classify epithelioid mediastinal malignancy. In this series examining poorly differentiated malignancies of the mediastinum, NMC is relatively frequent, occurring in approximately 10% of undifferentiated tumors. Therefore, the use of NUT IHC to evaluate for NMC should be considered in any poorly differentiated or undifferentiated epithelioid malignancy (with or without focal keratinization), particularly in the setting of otherwise negative immunohistochemical studies. Further advances in the treatment of NMC will require more widespread recognition of this aggressive malignancy.
